Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases.We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients.For the expansion of our Global Market Access Team, argenx is looking for a Market Access MG Lead.PURPOSE OF THE FUNCTIONIt is an exciting time of growth for argenx as we strive to achieve our VISION 2030. Vision 2030 is our long-term commitment to transform the treatment of autoimmune diseases by strengthening its leadership in neonatal Fc receptor (FcRn) biology, investing in its continuous pipeline of differentiated antibody candidates, and scaling in a disciplined way to ensure innovation remains core to the argenx mission. 'Vision 2030' includes the following goals: 50,000 patients globally on treatment with an argenx medicine, 10 labeled indications across all approved assets, including VYVGART and potentially empasiprubart and ARGX-119 and five new molecules in Phase 3 development.ROLES AND RESPONSIBILITIESDetermines early market access potential, pricing and strategy for pipeline indications and assets including indication sequencing, TPP, and TPLWork with Indication Development Teams (IDTs) to optimize trial designs so they reflect payer requirements, by incorporating feedback and needs from regional AccessCoordinate Early Scientific Advice from key HTA Agencies and conduct gap analyses with external consultantsWork with Indication Commercial Teams (ICTs) to align Access and Commercial positioning, pricing and strategyAssess unmet need, outline payer value proposition, assess P&R / HTA landscape and product outlookInform development of global pricing strategy and policyTest payer value messages, pricing expectations, and value proposition via Advisory Boards and research with payers / HTADevelop core value dossier and objection handlerDevelop innovative access strategies on a global and regional level incl. early access, and evaluate implications for launch (go, no-go risk mitigation and scenario planning)Build out and validate contracting options and G2N assumptionsPartner with HEOR and Regional Access to optimize the evidence generation plan, identify epidemiology and the unmet medical needInform the development of health economic and outcomes analyses (CEA, BIA, burden of disease, etc.) required for access, working in collaboration with internal cross-functional teamsFacilitate launch readiness workshops with regional and local Market Access and other functionsSKILLS AND COMPETENCIESHave experience and deep understanding of payer needs, decision-making approaches, strategies, and country reimbursement stakeholders and influencers in US and/or key EU marketsExperience in developing global and regional pricing and market access strategies and researchExperience working with clinical development teamsExperience working within launch and commercialization teams for therapies in the orphan and rare disease spaceExperience effectively managing external agency partners, and collaborating with cross-functional teams and internal/external stakeholders to effectively implement strategies and programsHighly organized, with demonstrated ability to effectively manage multiple priorities under pressureAbility to grasp highly technical concepts and to work within a deeply scientific environment; Exceptional learning agility, demonstrated by advancement in prior roles/companiesAbility to work collaboratively and effectively together within cross-functional teams and networksDemonstrated communication skills, within a multi-cultural and multi-lingual global environmentIs agile and demonstrates adaptability, comfort with ambiguity, trust-building, and resilienceDrives toward outcomesAmbitious, inquisitive naturally, a quick study, with demonstrated eagerness to continuously learn, self-improve and develop. This includes being comfortable givi #J-18808-Ljbffr
Director, Market Access Lead Arbeitgeber: argenx
Die Thommen Group bietet dir als Clinical Operations Innovator & Enablement Lead die Möglichkeit, in einem dynamischen und unternehmerisch geprägten Arbeitsumfeld zu arbeiten, das Innovation und Verantwortung fördert. Mit flexiblen Arbeitsmodellen und der Option auf Homeoffice unterstützt das Unternehmen eine ausgewogene Work-Life-Balance und bietet zahlreiche Entwicklungsmöglichkeiten, um deine Karriere voranzutreiben. Hier kannst du aktiv zur Gestaltung zukunftsweisender Lösungen im Recyclingbereich beitragen und Teil eines engagierten Teams werden, das Einfachheit und Effizienz in den Vordergrund stellt.
